Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Non-Current Debt (2017 - 2023)

Marimed (MRMD) has disclosed Non-Current Debt for 7 consecutive years, with $18.9 million as the latest value for Q3 2023.

  • Quarterly Non-Current Debt changed N/A to $18.9 million in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $18.9 million through Sep 2023, changed N/A year-over-year, with the annual reading at $17.3 million for FY2021, 61.6% up from the prior year.
  • Non-Current Debt for Q3 2023 was $18.9 million at Marimed, down from $20.5 million in the prior quarter.
  • The five-year high for Non-Current Debt was $20.8 million in Q1 2023, with the low at $46000.0 in Q1 2022.
  • Average Non-Current Debt over 5 years is $9.5 million, with a median of $10.7 million recorded in 2020.
  • The sharpest move saw Non-Current Debt tumbled 98.58% in 2022, then skyrocketed 45123.91% in 2023.
  • Over 5 years, Non-Current Debt stood at $300000.0 in 2019, then skyrocketed by 3460.74% to $10.7 million in 2020, then soared by 61.6% to $17.3 million in 2021, then tumbled by 99.73% to $46000.0 in 2022, then skyrocketed by 40976.09% to $18.9 million in 2023.
  • According to Business Quant data, Non-Current Debt over the past three periods came in at $18.9 million, $20.5 million, and $20.8 million for Q3 2023, Q2 2023, and Q1 2023 respectively.